RESUMO
Objective To show the recent trends in thyroid cancer in the United States, elucidate the characteristics of stage IV thyroid cancer, and consider the effects of diagnostic testing on the rising incidence of thyroid cancer. Design A retrospective population-based study conducted using the National Cancer Database from 2000-2013 (NCDB). Demographics of patients presenting with stage IV thyroid cancer were compared to patients presenting with all other stages using the chi-square testing. The incidence rates were examined with the trend graphs. Results When compared to stages I-III, there was an increased incidence of stage IV thyroid cancer in: Medicare, lower level of education, lower income, advanced age, male sex, increased number of comorbidities, further distance from a treatment facility, and medullary/anaplastic histology. The incidence of thyroid cancer increased from 7.1 per 100,000 in 2000 to 17.6 per 100,000 in 2013. During this same time period, stage IV disease increased 1 per 100,000. The increase in the incidence of thyroid cancer was almost entirely due to an increase in papillary cancer. Conclusions The United States has continued to see a rise in the incidence of thyroid cancer over the last decade, largely due to the detection of papillary cancers. During this same time, the incidence of stage IV thyroid cancer increased as well. Because early diagnosis and treatment of an increasing number of potentially lethal cancers should lead to a decrease in metastatic disease, we suggest that the increasing incidence of thyroid cancer in the United States is due to overdiagnosis and that more aggressive disease is not being removed by early detection.
